Theres new hope for people struggling with an addiction to cocaine.
Scientists at Novartis led the research, a Phase II trial of 68 people with diagnosed cocaine use disorder.
Cocaine and similar drugs like methamphetamine or prescription stimulants are frequently abused.
Over 10 million Americans misused stimulants like cocaine in 2022.© photopixel via Shutterstock
So theres an urgent need to fill this treatment gapone that could possibly be filled with mavoglurant.
So researchers hoped that mavoglurant could be retrofitted into a treatment for stimulant use disorder.
They also found evidence, though not as clear, that it reduced peoples alcohol use as well.
As the authors note, this is only one small trial.
So larger, more diverse, and longer-lasting trials will be needed to confirm the findings.
News from the future, delivered to your present.
You May Also Like
Millions Share a Deadly Genetic Heart Risk.
A Pill for Ebola?
